啟始時間 | 標題 | P-Investigator | 經費來源 |
2019 | 108年度「重點科別培育公費醫師制度輔導計畫」 | SHAN-CHWEN CHANG | Ministry of Health and Welfare |
2019 | Follow-up study of the Immunogeneity and Safety of a Live Attenuated Tetravalent Dengue Vaccine TV005 among Taiwanese Adults 50 to 70 Years of Age: a Phase II Clinical Trial | SHAN-CHWEN CHANG | Ministry of Health and Welfare |
2019 | Precision Medicine Research Center (II) | SHAN-CHWEN CHANG | National Science and Technology Council |
2019 | The Promotion and Counselling Program of the Automatic Notification System for Antimicrobial Resistance | SHAN-CHWEN CHANG | Ministry of Health and Welfare |
2019 | The Study of the Emerging and Re-Emerging Infectious Disease in Taiwan(II) | SHAN-CHWEN CHANG | National Science and Technology Council |
2019 | 建立臺灣醫用微生物叢跨領域轉譯平台計畫-第三期 | SHAN-CHWEN CHANG | Academia Sinica |
2019 | 高等教育深耕計畫-特色領域研究中心-【精準醫學研究中心】 | SHAN-CHWEN CHANG | Higher Education Sprout Project |
2018 | 106 年重點科別培育公 費醫師制度輔導計畫 | SHAN-CHWEN CHANG | Ministry of Health and Welfare |
2018 | Precision Medicine Research Center(1/5) | SHAN-CHWEN CHANG | National Science and Technology Council |
2018 | The Promotion and Counselling Program of the Automatic Notification System for Antimicrobial Resistance | SHAN-CHWEN CHANG | Ministry of Health and Welfare |
2017 | Taiwan Clinical Trial Consortium for Infectious Diseases | SHAN-CHWEN CHANG | National Science and Technology Council |
2017 | The Immunogeneity and Safety of a Live Attenuated Tetravalent Dengue Vaccine TV005 among Taiwanese Adults 50 to 70 Years of Age: a Phase II Clinical Trial | SHAN-CHWEN CHANG | Centers for Disease Control , R.O.C. |
2017 | The Promotion and Counselling Program of the Automatic Notification System for Antimicrobial Resistance | SHAN-CHWEN CHANG | Ministry of Health and Welfare |
2016 | In vitro Susceptibilities of Methicillin-Resistant Staphylococcus sureus to Different Oral Antibiotics: Detection of Associated Drug Resistance Genes | SHAN-CHWEN CHANG | National Science and Technology Council |
2016 | Epidemiology and clinical characteristics of endemic severe influenza during 2015-2016 | SHAN-CHWEN CHANG | National Science and Technology Council |
2016 | Taiwan Clinical Trial Consortium of Infectious Disease | SHAN-CHWEN CHANG | National Science and Technology Council |
2016 | The Program Project for Frontiers in Vaccine Technology Development---Continued Project | SHAN-CHWEN CHANG | National Science and Technology Council |
2016 | 臺灣醫學會雜誌 | SHAN-CHWEN CHANG | Ministry of Health and Welfare |
2015 | In vitro Susceptibilities of Methicillin-Resistant Staphylococcus sureus to Different Oral Antibiotics: Detection of Associated Drug Resistance Genes | SHAN-CHWEN CHANG | National Science and Technology Council |
2015 | Taiwan Clinical Trial Consortium for Infectious Disease (II) | SHAN-CHWEN CHANG | National Science and Technology Council |
2015 | The Program Project for Frontiers in Vaccine Technology Development-Continued Project | SHAN-CHWEN CHANG | National Science and Technology Council |
2015 | 臺灣醫學會雜誌 | SHAN-CHWEN CHANG | Ministry of Health and Welfare |
2014 | The Program Project for Frontiers in Vaccine Technology Development-Continued Project | SHAN-CHWEN CHANG | National Science and Technology Council |
2014 | Setting up Taiwan Infectious Disease Consortium and Databank of Infectious Diseases (I) | SHAN-CHWEN CHANG | National Science and Technology Council |
2014 | 臺灣醫學雜誌 | SHAN-CHWEN CHANG | Ministry of Health and Welfare |
2013 | A Randomized, Double-Blind, Controlled Phase I Trial to Evaluate the Safety, Tolerability, and Immunogenicity of DCB07010 Adjuvant Given Intranasally at Ascending Dose Levels and Co-Administered with Trivalent Inactivated Influenza Virus Antigen (II) | SHAN-CHWEN CHANG | National Science and Technology Council |
2013 | An Open-Label, Dose-Escalating Phase 1 Safety Study of HibmLT Vaccine in Healthy Volunteers (I) | SHAN-CHWEN CHANG | National Science and Technology Council |
2013 | The Program Project for Frontiers in Vaccine Technology Development | SHAN-CHWEN CHANG | National Science and Technology Council |
2013 | Plan for improvement for anti-tuberculosis regimens | SHAN-CHWEN CHANG | Centers for Disease Control , R.O.C. |
2012 | A Randomized, Double-Blind, Controlled Phase I Trial to Evaluate the Safety, Tolerability, and Immunogenicity of DCB07010 Adjuvant Given Intranasally at Ascending Dose Levels and Co-Administered with Trivalent Inactivated Influenza Virus Antigen (I) | SHAN-CHWEN CHANG | National Science and Technology Council |
2012 | Establish Standard of Care and Rapid Molecular Diagnostic Methods of Invasive Fungal Infection | SHAN-CHWEN CHANG | National Science and Technology Council |
2012 | The Program Project for Frontiers in Vaccine Technology Development | SHAN-CHWEN CHANG | National Science and Technology Council |
2012 | Assessment for the effectiveness of early interventions for the inadequate regimens for anti- tuberculosis treatment | SHAN-CHWEN CHANG | Ministry of Health and Welfare |
2012 | Clinical and Microbiological Investigation for Carbapenemase-Resistant, Including NDM-1-Producing, Enterobacteriaceae (I) | SHAN-CHWEN CHANG | National Science and Technology Council |
2011 | Establish Standard of Care and Rapid Molecular Diagnostic Methods of Invasive Fungal Infection | SHAN-CHWEN CHANG | National Science and Technology Council |
2010 | Establish Standard of Care and Rapid Molecular Diagnostic Methods of Invasive Fungal Infection | SHAN-CHWEN CHANG | National Science and Technology Council |